← Back to Search

CBTI-PE for Post-Traumatic Stress Disorder

N/A
Waitlist Available
Led By Peter Colvonen, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post treatment (14-weeks), follow-up (26-weeks)
Awards & highlights

Study Summary

This trial is examining whether adding a treatment for insomnia to standard PTSD treatment will improve sleep, PTSD symptoms, and quality of life for veterans.

Eligible Conditions
  • Post-Traumatic Stress Disorder
  • Chronic Insomnia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in PTSD Symptoms
Secondary outcome measures
Change in Quality of Life
Change in Sleep Efficiency
Other outcome measures
Medications Use Interview
Nox T3 recorders - Obstructive Sleep Apnea (OSA)
Pain Disability Questionnaire (PDQ)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CBTI-PEExperimental Treatment1 Intervention
Integrates the core components of CBT-I and PE in 14 90-minute weekly sessions.
Group II: Hygiene-PEActive Control1 Intervention
Uses non-active sleep hygiene to account for the dose response of experimental condition before starting PE. Uses 14 90-minute weekly sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CBTI-PE
2016
N/A
~100

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,361 Total Patients Enrolled
Peter Colvonen, PhDPrincipal InvestigatorVA San Diego Healthcare System, San Diego, CA
1 Previous Clinical Trials
194 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Journal of Clinical Sleep MedicineJournal
STOP-BANG Screener Vs Objective Obstructive Sleep Apnea Testing Among Younger Veterans with PTSD and Insomnia: STOP-BANG Does Not Sufficiently Detect Risk
Lyons, Robert, Lara A. Barbir, Robert Owens, and Peter J. Colvonen. 2022. “STOP-BANG Screener Vs Objective Obstructive Sleep Apnea Testing Among Younger Veterans with PTSD and Insomnia: STOP-BANG Does Not Sufficiently Detect Risk”. Journal of Clinical Sleep Medicine. American Academy of Sleep Medicine (AASM). doi:10.5664/jcsm.9498.
Journal of Clinical Sleep MedicineJournal
STOP-BANG Screener Vs Objective Obstructive Sleep Apnea Testing Among Younger Veterans with PTSD and Insomnia: STOP-BANG Does Not Sufficiently Detect Risk
Lyons, Robert, Lara A. Barbir, Robert Owens, and Peter J. Colvonen. 2022. “STOP-BANG Screener Vs Objective Obstructive Sleep Apnea Testing Among Younger Veterans with PTSD and Insomnia: STOP-BANG Does Not Sufficiently Detect Risk”. Journal of Clinical Sleep Medicine. American Academy of Sleep Medicine (AASM). doi:10.5664/jcsm.9498.
clinicaltrials.govStudy
Integrated CBT-I and PE on Sleep and PTSD Outcomes (Impact Study)
2016. "Integrated CBT-I and PE on Sleep and PTSD Outcomes (Impact Study)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02774642.
~11 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top